BLFSBioLife Solutions, Inc.
23.95USD-3.19%Mkt Cap: 1.17B USDP/E: Last update: 2026-05-22

BioLife Solutions, Inc. develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The…

loading…
Indicators:|

Key Statistics

Company
Market Cap1.17B USD
Enterprise Value1.14B USD
Revenue (TTM)101.66M USD
Gross Profit62.12M USD
Net Income (TTM)-4.59M USD
Revenue/Share2.114 USD
Last Price23.95 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees155
CountryUS
SectorHealthcare
IndustryMedical Instruments & Supplies
ISIN
Valuation
P/E (Trailing)
P/E (Forward)85.31
PEG15.09
EV/EBITDA264.43
EV/Revenue11.24
P/S11.89
P/B3.25
EPS (TTM)-0.24
EPS (Forward)0.29
52W Range
17.8652% of range29.62
52W High29.62 USD
52W Low17.86 USD
Profitability
Gross Margin64.56%
Oper. Margin0.10%
EBITDA Margin4.25%
Profit Margin-4.78%
ROE-1.24%
ROA-1.13%
Growth
Revenue Growth24.70%
Earnings Growth
Cash Flow & Leverage
Operating CF20.11M USD
CapEx (TTM)19.70M USD
FCF Margin6.29%
FCF Yield0.55%
Net Debt-66.14M USD
Net Debt/EBITDA-15.31
Balance Sheet
Debt/Equity0.05
Current Ratio7.30
Quick Ratio5.15
Book Value/Sh7.624 USD
Cash/Share1.658 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Splits
Last Split1:14
Split DateJan 29, 2014
Analyst Consensus
Rating1.1 (Strong Buy)
Target (Mean)32.30 USD
Target Range30.00 USD34.00 USD
# Analysts10
Ownership
Shares Out.48.86M
Float41.64M
Insiders2.39%
Institutions107.22%
Short Interest
Short Ratio9.9d
Short % Float11.62%
Short % Out.7.43%
Shares Short3.63M
Short (prev mo.)3.60M
Technical
SMA 5020.66 (+15.9%)
SMA 20023.81 (+0.6%)
Beta1.97
S&P 52W Chg28.31%
Avg Vol (30d)495.24K
Avg Vol (10d)678.81K
Technical Indicators
RSI (14)
MACD
MACD Signal
MACD Hist.
BB Upper
BB Middle
BB Lower
BB Width
ATR (14)
Vol Ratio (20d)